Mode-of-action analysis for induction of rat liver tumors by pyrethrins: Relevance to human cancer risk

Critical Reviews in Toxicology

Volumn 39, Issue 6, 2009, Pages 501-511

  Osimitz, Thomas G ^a   Lake, Brian G ^b,c  

^a Science Strategies LLC   (United States)

^b LFI Molecular Sciences   (United Kingdom)

^c UNIVERSITY OF SURREY   (United Kingdom)

Author keywords

Cell proliferation; Cytochrome P 450 induction; Liver carcinogenesis; Mode of action; Pyrethrins

Indexed keywords

ANDROGEN; ANDROSTANE RECEPTOR; DNA; PHENOBARBITAL; PYRETHROID; UNCLASSIFIED DRUG;

APOPTOSIS; CANCER INCIDENCE; CANCER RISK; CARCINOGENESIS; CARCINOGENICITY; CELL COMMUNICATION; CYTOTOXICITY; DNA SYNTHESIS; GAP JUNCTION; HUMAN; LIVER HYPERTROPHY; LIVER TUMOR; MUTAGENICITY; NONHUMAN; PEROXISOME; PORPHYRIA; REVIEW;

ANIMALS; CARCINOGENS; CELL TRANSFORMATION, NEOPLASTIC; HUMANS; INSECTICIDES; LIVER NEOPLASMS; PYRETHRINS; RISK ASSESSMENT;

RATTUS; RODENTIA;

EID: 70350513895     PISSN: 10408444     EISSN: 15476898     Source Type: Journal    
DOI: 10.1080/10408440902914014     Document Type: Review

References (60)

1. Agency for Toxic Substances and Disease Registry (ATSDR) (2003). ToxFAQs™ for pyrethrins and pyrethroids-September 2003. U.S. Department of Health and Human Services, Atlanta, GA
2. Baker, T.K., Bachowski, S., Stevenson, D.E., Walborg, E.F., Jr., and Klaunig, J.E. (1995). Modulation of gap junctional intercellular communication in rodent, monkey and human hepatocyte by nongenotoxic compounds. Prog. Clin. Biol. Res. 391: 71-80
3. Bentley P., Calder I., Elcombe C., Grasso P., Stringer D., and Wiegand H.-J. (1993). Hepatic peroxisome proliferation in rodents and its signifcance for humans. Food Chem. Toxicol. 31: 857-907
4. Bhat, B.K. (1995). Breeding methodologies applicable to pyrethrum. In: Pyrethrum Flowers Production, Chemistry, Toxicology, and Uses, J.E Casida and G.B. Quistad, eds., pp. 67-94
5. Boobis, A.R., Cohen, S.M., Dellarco, V., McGregor, D., Meek, B.E., Vickers, C., Willcocks, D., and Farland, W. (2006). IPCS framework for analyzing the relevance of a cancer mode of action for humans. Crit. Rev. Toxicol. 36: 781-792 (Pubitemid 44800328)
6. Casida J.E., and Quistad, G.B. (1995). Metabolism and synergism of pyrethrins. In: Pyrethrum Flowers Production, Chemistry, Toxicology, and Uses, J.E Casida and G.B. Quistad, eds., pp. 258-276
7. Chang, T.K.H., Yu, L., Maurel, P., and Waxman, D.J. (1997). Enhanced cyclophosphamide and ifosfamide activation in primary human hepatocyte cultures: Response to cytochrome P-450 inducers and autoinduction by oxazaphosphorines. Cancer Res. 57: 1946-1954
8. Chipman, J.K., Mally, A., and Edwards, G.O. (2003). Disruption of gap junctions in toxicity and carcinogenicity. Toxicol. Sci. 71: 146-153
9. Cohen, S.M., Klaunig, J., Meek, M.E., Hill, R.N., Pastoor, T., Lehman-McKeeman, L., Bucher, J., Longfellow, D.G., Seed, J., Dellarco, V., Fenner-Crisp, P., and Patton, D. (2004). Evaluating the human relevance of chemically induced animal tumors. Toxicol. Sci. 78: 181-186
10. Cohen, S.M., Meek, M.E., Klaunig, J.E., Patton, D.E., and Fenner-Crisp, P.A. (2003). Te human relevance of information on carcinogenic modes of action: Overview. Crit. Rev. Toxicol. 33: 581-589
11. Crampton, R.F., Gray, T.J.B., Grasso, P., and Parke, D.V. (1977). Long-term studies on chemically induced liver enlargement in the rat. I. Sustained induction of microsomal enzymes with absence of liver damage on feeding phenobarbitone or butylated hydroxytoluene. Toxicology 7: 289-306 (Pubitemid 8137135)
12. Cunningham, M.L. (1996). Role of increased DNA replication in the carcinogenic risk of nonmutagenic chemical carcinogens. Mutat. Res. 365: 59-69
13. Dellarco, V.L., McGregor, D., Berry, C., Cohen, S.M., and Boobis, A.R. (2206). Tiazopyr and thyroid disruption: Case study within the context of the 2006 IPCS Human Relevance Framework for Analysis of a Cancer Mode of Action. Crit. Rev. Toxicol. 36: 792-801
14. Doull, J., Cattley, R., Elcombe, C., Lake, B.G., Swenberg, J., Wilkinson, C., Williams, G., and van Gemert, M., 1999. A cancer risk assessment of di(2-ethylhexyl)phthalate: Application of the new U.S. EPA Risk Assessment Guidelines. Regul. Toxicol. Pharmacol. 29: 327-357
15. Finch, J.M., Osimitz, T.G., Gabriel, K.L., Martin, T., Henderson, W.J., Capen, C.C., Butler, W.H., and Lake, B.G. (2006). A mode of action for induction of thyroid gland tumors by pyrethrins in the rat. Toxicol. Appl. Pharmacol. 214: 253-262
16. Gerbal-Chaloin, S., Pascussi, J.-M., Pichard-Garcia, L., Daujat, M., Waechter, F. , Fabre, J.-M., Carrère, N., and Maurel, P. 2001. Induction of CYP2C genes in human hepatocytes in primary culture. Drug Metab. Dispos. 29: 242-251
17. Gerberg, E.J. (1995). Pyrethrum for control of pests of medical and veterinary importance. In: Pyrethrum Flowers Production, Chemistry, Toxicology, and Uses, J.E Casida and G.B. Quistad, eds., pp. 302-310 Oxford University Press, New York.
18. Gold, L.S., Manley, N.B., Slone, T.H., and Ward, J.M. (2001). Compendium of chemical carcinogens by target organ: results of chronic bioassays in rats, mice, hamsters, dogs, and monkeys. Toxicol. Pathol. 29: 639-652
19. Grasso, P., and Hinton, R.H. (1991). Evidence for and possible mechanisms of non-genotoxic carcinogenesis in rodent liver. Mutat. Res. 248: 271-290
20. Hasmall, S.C., and Roberts, R.A. (1999). Te perturbation of apoptosis and mitosis by drugs and xenobiotics. Pharmacol Ter. 82: 63-70
21. Holsapple, M.P., Pitot, H.C., Cohen, S.H., Boobis, A.R., Klaunig, J.E., Pastoor, T., Dellarco, V.L., and Dragan, Y.P. (2006). Mode of action in relevance of rodent liver tumors to human cancer risk. Toxicol. Sci. 89: 51-56
22. Honkakoski, P., and Negishi, M. (2000). Regulation of cytochrome P450 (CYP) genes by nuclear receptors. Biochem. J. 347:321-337
23. Huang, W., Zhang, J., Wahington, M., Liu, J., Parant, J.M., Lozano, G., and Moore, D.D., 2005. Xenobiotic stress induces hepatomegaly and liver tumors via the nuclear receptor constitutive androstane receptor. Mol. Endocrinol. 19: 1646-1653
24. Huf, J., Cirvello, J., Haseman, J., and Bucher, J. (1991). Chemicals associated with site-specifc neoplasia in 1394 long-term carcinogenesis experiments in laboratory rodents. Environ. Health Perspect. 93: 247-270
25. Hurley, P.M., Hill, R.N., and Whiting, R.J. (1998). Mode of carcinogenic action of pesticides inducing thyroid follicular cell tumors in rodents. Environ. Health Perspect. 106: 437-445
26. IARC (2001). IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Volume 79. Some Tyrotropic Agents. IARC Press, Lyon
27. Kennedy, M.K., and Hamilton, R.L. (1995). Pyrethrum for control of insects in the home. In: Pyrethrum Flowers Production, Chemistry, Toxicology, and Uses, J.E Casida and G.B. Quistad, eds., pp. 311-327, Oxford University Press, New York.
28. Klaunig, J.E. (2006). Examination of mode of action of pyrethrins tumorigenesis in mammals. Unpublished report submitted to U.S. EPA (MRID No. 46792704
29. Klaunig, J.E., Ruch, R.J., and Weghorst, C.M. (1990). Comparative efects of phenobarbital, DDT, and lindane on mouse hepatocyte gap junctional intercellular communication. Toxicol. Appl. Pharmacol. 102: 553-563
30. Klaunig, J.E., Babich, M.A., Baetcke, K.P., Cook, J.C., Corton, J.C., David, R.M., DeLuca, J.G., Lai, D.Y., McKee, R.H., Peters, J.M., Roberts, R.A., and Fenner-Crisp, P.A. (2003). PPAR-alpha agonist-induced rodent tumors: Modes of action and human relevance. Crit. Rev. Toxicol. 33: 655-780
31. Kolaja, K.L., Stevenson, D.E., Johnson, J.T., Walborg, E.F., Jr., and Klaunig, J.E. (1996). Subchronic efects of dieldrin and phenobarbital on hepatic DNA synthesis in mice and rats. Fundam. Appl. Toxicol. 29:219-228
32. Lake, B.G. (1995). Mechanisms of hepatocarcinogenicity of peroxisome-proliferating drugs and chemicals. Annu. Rev. Pharmacol. Toxicol. 35: 483-507
33. Lake, B.G., Longland, R.C., Harris, R.A., Severn, B.J., and Gangolli, S.D. (1978). Te efect of prolonged sodium phenobarbitone treatment on hepatic xenobiotic metabolism and the urinary excretion of metabolites of the D-glucuronic acid pathway in the rat. Biochem. Pharmacol. 27: 2357-2361
34. Madan, A., Graham, R.A., Carroll, K.M., Mudra, D.R., Burton, L.A., Krueger, L.A., Downey, A.D., Czerwinski, M., Forster, J., Ribadeneira, M.D., Gan, L.-S., LeCluyse, E.L., Zech, K., Robertson, P., Jr., Koch, P., Antonian, L., Wagner, G., Yu, L., and Parkinson, A. (2003). Efects of prototypical microsomal enzyme inducers on cytochrome P450 expression in cultured human hepatocytes. Drug Metab. Dispos. 31: 421-431
35. Meek, M.E., Bucher, J.R., Cohen, S.M., Dellarco, V., Hill R.N., Lehman-McKeeman, L.D., Longfellow, D.G., Pastoor, T., Seed, J, and Patton, D.E. (2003). A framework for human relevance analysis of information on carcinogenic modes of action. Crit. Rev. Toxicol. 33: 591-653
36. Moore, J.T., Moore, L.B., Maglich, J.M., and Kliewer, S.A. (2003). Functional and structural comparison of PXR and CAR. Biochim. Biophys. Acta 1619: 235-238
37. Neveu, M.J., Babcock, K.L., Hertzberg, E.L., Paul, D.L., Nicholson, B.J., and Pitot, H.C. (1994). Colocalized alterations in connexin32 and cytochrome P450IIB1/2 by phenobarbital and related liver tumor promoters. Cancer Res. 54: 3145-3152
38. Nims, R.W., and Lubet, R.A. (1996). Te CYP2B subfamily, In: Cytochromes P450: Metabolic and Toxicological Aspects, C. Ioannides ed., pp. 135-160
39. CRC Press, Boca Raton, FL. Olsen, J.H., Boice, J.D., Jr, Jensen, J.P.A., and Fraumeni, J.F., Jr. (1989). Cancer among epileptic patients exposed to anticonvulsant drugs. J. Natl. Cancer Inst. 81: 803-808
40. Olsen, J.H., Schulgen, G., Boice, J.D., Jr, Whysner, J., Travis, L.B., Williams, G.M., Johnson, F.B., and McGee, J.O.D. (1995). Antiepileptic treatment and risk for hepatobiliary cancer and malignant lymphoma. Cancer Res. 55: 294-297
41. Orton, T.C., Doughty, S.E., Kalinowski, A.E., Lord, P.G., and Wadsworth, P.F. (1996). Expression of growth factors and growth factor receptors in the liver of C57BL/10J mice following administration of phenobarbitone. Carcinogenesis 17: 973-981
42. Parkinson, A. (2001). Biotransformation of xenobiotics, In: Casarett and Doull's Toxicology: Te Basic Science of Poisons, 6th edition, C.D. Klaassen, ed., pp. 133-224
43. Parzefall, W. Erber, E., Sedivy, R., and Schulte-Hermann, R. (1991). Testing for induction of DNA synthesis in human hepatocyte primary cultures by rat liver tumor promoters. Cancer Res. 51: 1143-1147
44. Pelkonen, O., Mäenpää, J., Taavitsainen, P., Rautio, A., and Raunio, H. (1998). Inhibition and induction of human cytochrome P450 (CYP) enzymes. Xenobiotica 28:1203-1253 (Pubitemid 29017141)
45. Phillips, J.C., Price, R.J., Cunninghame, M.E., Osimitz, T.G., Cockburn, A., Gabriel, K.L., Preiss, F., Butler, W.H., and Lake, B.G. (1997). Efect of piperonyl butoxide on cell replication and xenobiotic metabolism in the livers of CD-1 mice and F344 rats. Fundam. Appl. Toxicol. 38: 64-74
46. Pirttiaho H.I., Sotaniemi E.A., Ahokas, J.T., and Pitkänen U. (1978). Liver size and indices of drug metabolism in epileptics. Brit.. J. Clin. Pharmacol. 6: 273-278
47. Pirttiaho H.I., Sotaniemi E.A., Pelkonen, R.O., and Pitkänen U. (1982). Hepatic blood fow and drug metabolism in patients on enzyme-inducing anticonvulsants. Eur. J. Clin. Pharmacol. 22: 441-445
48. Price, R.J., Giddings, A.M., Scott, M.P., Walters, D.G., Capen, C.C., Osimitz, T.G., and Lake, B.G. (2008). Efect of pyrethrins on cytochrome P450 forms in cultured rat and human hepatocytes. Toxicology 243: 84-95
49. Price, R.J., Walters, D.G., Finch, J.M., Gabriel, K.L., Capen, C.C., Osimitz, T.G., and Lake, B.G. (2007). A mode of action for induction of liver tumors by pyrethrins in the rat. Toxicol. Appl. Pharmacol. 218: 186-195
50. Schoenig, G.P., 1995. Mammalian toxicology of pyrethrum extract. In: Pyrethrum Flowers Production, Chemistry, Toxicology, and Uses, J.E Casida and G.B. Quistad, eds., pp. 249-257 Oxford University Press
51. Silcox, C.A., and Roth, E.S. (1995). Pyrethrum for control of pests of agricultural and stored products. In: Pyrethrum Flowers Production, Chemistry, Toxicology, and Uses, J.E Casida and G.B. Quistad, eds., pp. 287-301
52. Sonich-Mullin, C., Fielder, R., Wiltse, J., Baetcke, K., Dempsey, J., Fenner-Crisp, P., Grant, D., Hartley, M., Knaap, A., Kroese, D., Mangelsdorf, I., Meek, E., Rice, J.M., and Younes, M. (2001). IPCS conceptual framework for evaluating a mode of action for chemical carcinogenesis. Regul. Toxicol. Pharmacol. 34:146-152
53. Tien, E.S., and Negishi, M. (2006). Nuclear receptors CAR and PXR in the regulation of hepatic metabolism. Xenobiotica 36: 1152-1163
54. U.S., Environmental Protection Agency (EPA) (2005). Pyrethrins: Revised Human Health Risk Assessment for the Reregistration Eligibility Decision. Case No. 2580. PC Code: 069001; DP Barcode: D321641. September 14
55. U.S., Environmental Protection Agency (EPA) (2008). Evaluation of the Carcinogenic Potential of pyrethrins (Fourth Review), PC code 069001. Cancer Assessment Review Committee, Health Efects Division, Ofce of Pesticide Programs, Washington, DC. February 14
56. Wei, P., Zhang, J., Egan-Hafey, M., Liang, S., and Moore, D.D. (2000). Te nuclear receptor CAR mediates specifc xenobiotic induction of drug metabolism. Nature 407: 920-923
57. Whysner, J., Ross, P.M., and Williams, G.M. (1996). Phenobarbital mechanistic data and risk assessment: Enzyme induction, enhanced cell proliferation, and tumor promotion. Pharmacol. Ter. 71: 153-191 (Pubitemid 26323295)
58. Yamamoto, Y., Moore, R., Goldsworthy, T.L., Negishi, M., and Maronpot, R.R. (2004). Te orphan nuclear receptor constitutive active/androstane receptor is essential for liver tumor promotion by phenobarbital in mice. Cancer Res. 64: 7197-7200
59. Yoshinari, K., Tien, E., Negishi, M., and Honkakoski, P., (2008). Receptor-mediated regulation of cytochromes P450. In: Cytochromes P450: Role in the Metabolism and Toxicity of Drugs and Other Xenobiotics, C. Ioannides ed., pp. 417-448
60. Albertini, R.J., and Sweeney, L.M. (2007). Propylene oxide: Genotoxicity profle of a rodent nasal carcinogen. Crit. Rev. Toxicol 37 489-520